NO EVIDENCE OF OSTEOPOROSIS IN YOUNG HTLV-1-INFECTED CARRIERS

Autores

  • Antonio Carlos Silva Santos
  • Ney Boa Sorte
  • Carolina Carneiro de Campos
  • Sandra Rocha Gadelha
  • Maria Fernanda Rios Grassi
  • Marcos Almeida Matos
  • Bernardo Galvão Castro

DOI:

https://doi.org/10.17267/2317-3386bjmhh.v2i2.420

Palavras-chave:

HTLV-1, Bone mineral density, Osteoporosis

Resumo

Osteoporosis has been reported among Human T-cell Lymphotropic Virus type 1 (HTLV-1) infected aged patients with HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) diagnosis. However, the association between osteoporosis and HTLV-1 infection remains unclear. This study aimed to evaluate the presence of bone disorders in young HTLV-1 asymptomatic individuals. A cross sectional study was carried out at the HTLV Reference Center in Salvador, Brazil. Forty-seven HTLV-1 infected asymptomatic and 108 healthy subjects aged between 20 to 45 years were included. Biochemical markers of bone metabolism were measured and bone mineral density (BMD) was determined at the femoral neck and at the lumbar spine (L1 -L4). Significant low BMD (Z-score <-1 ) was found in HTLV-1 infected individuals (1.177 ± 0.103) compared to control subjects (1.225 ± 0.146). In logistics regression analysis HTLV-1 infected subjects were more likely to have low BMD (OR = 3.48; 95%CI 1.29- 9.43) adjusted for low education and body mass index (BMI). Osteoporosis (Z-score <-2) was not found among HTLV-1-infected group. In conclusion, our results found a low BMD in patients infected with HTLV-1 compared to uninfected controls. However, osteoporosis was not observed. Further studies should be conducted to evaluate the relationship between HTLV-1-infection and low BMD.

Biografia do Autor

  • Antonio Carlos Silva Santos
    MD, PhD, Integrative and multidisciplinary Centre of HTLV, Bahiana School of Medicine and Public Health
  • Ney Boa Sorte
    MD, PhD, Integrative and multidisciplinary Centre of HTLV, Bahiana School of Medicine and Public Health
  • Carolina Carneiro de Campos
    Integrative and multidisciplinary Centre of HTLV, Bahiana School of Medicine and Public Health
  • Sandra Rocha Gadelha
    PhD State University of Santa Cruz (UESC), Itabuna – Bahia
  • Maria Fernanda Rios Grassi
    MD, PhD, Integrative and multidisciplinary Centre of HTLV, Bahiana School of Medicine and Public Health(EBMSP), Salvador – Bahia- Brazil; Advanced Public Health Laboratory, Gonçalo Moniz Research Center, Oswaldo Cruz Foundation (Fiocruz),Salvador – Bahia
  • Marcos Almeida Matos
    MD, PhD, Integrative and multidisciplinary Centre of HTLV, Bahiana School of Medicine and Public Health
  • Bernardo Galvão Castro
    MD, PhD, Integrative and multidisciplinary Centre of HTLV, Bahiana School of Medicine and Public Health(EBMSP), Salvador – Bahia- Brazil; Advanced Public Health Laboratory, Gonçalo Moniz Research Center, Oswaldo Cruz Foundation (Fiocruz),Salvador – Bahia

Downloads

Publicado

2014-08-01

Edição

Seção

Artigos Originais